Purchases and Sales Made in Q4 2022 in Ayala Pharmaceuticals, Inc. (AYLA)
This table provides information about the institutional ownership of Ayala Pharmaceuticals, Inc. (AYLA) during Q4 2022. The information is specifically focused on institutions that hold shares of Ayala Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
11.4KNew |
$4.34K - $8.1K
|
11.4K
$0
|
|
Feb 09, 2023
Q4 2022
|
Avantax Planning Partners, Inc.
|
BUY
|
- |
10KNew |
$3.8K - $7.1K
|
10K
$0
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
5.6K+ 11.67% |
$2.13K - $3.98K
|
53.6K
$0
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
1.01KNew |
$384 - $717
|
1.01K
$0
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.4K- 14.7% |
$912 - $1.7K
|
13.9K
$0
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-5.16K- 24.32% |
$1.96K - $3.67K
|
16.1K
$0
|
|
Jan 30, 2023
Q4 2022
|
Psagot Value Holdings Ltd.
Tel Aviv, L3 |
SELL
|
- |
-24.8K- 40.62% |
$9.42K - $17.6K
|
36.2K
$0
|
|
Feb 14, 2023
Q4 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-25K- 30.53% |
$9.5K - $17.8K
|
56.9K
$0
|